Exploring association between reduced HPV infection and genetic variations in Western Asia

April 10, 2017, Wiley
Electron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domain

New research provides an insight into why cervical cancer is less common in certain regions of the world even though they may have limited screening and fewer or no prevention programs. Though the preliminary findings, published early online in Cancer, a peer-reviewed journal of the American Cancer Society, don't rule out a cultural explanation or other reasons, they explore how genetic factors may also help explain this trend.

Approximately eight out of 10 deaths worldwide occur in low- and middle-income countries, but a few geographical regions—such as Western Asia including Saudi Arabia—have low cervical rates despite the lack of national screening or vaccination programs against human papillomavirus (HPV), which is transmitted sexually and is the main cause of cervical cancer.

Ghazi Alsbeih, MD, PhD, of the King Faisal Specialist Hospital & Research Centre in Saudi Arabia, and his colleagues collected tumor samples and demographic data from 232 patients treated for invasive cervical cancers and compared the information with 313 matched controls without cancer.

The researchers found that cervical cancer in their Saudi national cohort displayed two peaks of increased incidence at 43 and 61 years of age. "As cancer development takes years to decades, the first peak could be a consequence of early sexual encounters, which often occurs at the end of the teenage period to the early thirties, while the second rebound could correspond to new encounters later in life," explained Dr. Alsbeih. "The latter is generally occasioned by separation, failure of a first marriage, or simply second marriages in polygamous societies, which brings in an added risk of HPV infections as the number of lifetime sexual partners increases."

Worldwide, 85 percent to 99 percent of patients with cervical cancer are HPV-positive, but in this study, only 77 percent were.

Dr. Alsbeih and his colleagues looked to genetics to explore why cervical cancer rates may be lower in Saudi Arabia than in other regions such as the United States. They found that HPV-negative patients in this study were more likely to show a particular variant in the gene that encodes the protein: a cytosine (C) rather than a guanine (G) in the DNA code, which leads to the production of a proline rather than an arginine amino acid in the translated protein. The authors hypothesize that this C variant therefore could be associated with a reduced likelihood for HPV infection. Less HPV cervical infection is associated with less cervical cancer risk. Though the G allele is considered the majority allele, the C variant was more commonly observed in this cohort than it is in populations from other parts of the world that show higher incidences of cervical cancer.

The optimistic conclusion about a protective role for this genetic variant is provocative, but the authors acknowledge that differing cultural norms could also help explain the lower rates of cervical cancer in Saudi Arabia.

Infection with HPV is the most common (STD) in the United States. April is STD Awareness Month.

Explore further: Screening, HPV vaccine can prevent cervical cancer: FDA

More information: Ghazi A. Alsbeih et al, Reduced rate of human papillomavirus infection and genetic overtransmission of72C polymorphic variant lower cervical cancer incidence, Cancer (2017). DOI: 10.1002/cncr.30635

Related Stories

Screening, HPV vaccine can prevent cervical cancer: FDA

February 8, 2017
(HealthDay)—Women can reduce their risk of cervical cancer through vaccination and screening, the U.S. Food and Drug Administration says.

Cervical cancer is preventable, but still a leading cancer

January 11, 2017
At the beginning of the year, many women (and men) set resolutions around health and fitness, often focusing on weight loss. But one of the most important habits women can form revolves around regular health checks, particularly ...

Low incidence of cervical cancer, CIN3+ for HPV-negative women

October 7, 2016
(HealthDay)—Human papillomavirus (HPV)-negative women have low long-term incidence of cervical cancer and cervical intraepithelial neoplasia (CIN) grade 3 or worse (CIN3+), which supports an extension of the cervical screening ...

Cervical cancer gene discovery may boost remedy quest

January 24, 2017
Cervical cancer comes in subtypes, said a study Monday that may boost the quest for life-saving treatments for a disease experts said is killing more women than previously thought.

More than two-thirds of cervical cancer deaths prevented by screening

September 19, 2016
Cervical screening prevents 70 per cent of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83 per cent, according to research led by Queen Mary University of London (QMUL).

HPV vaccine reduced cervical abnormalities in young women

July 4, 2016
Young women who received the human papillomavirus (HPV) vaccine through a school-based program had fewer cervical cell anomalies when screened for cervical cancer, found a new study in CMAJ (Canadian Medical Association Journal).

Recommended for you

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

New insight into stem cell behaviour highlights therapeutic target for cancer treatment

December 12, 2018
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.